BlackRock Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $866K | Buy |
57,381
+1,302
| +2% | +$19.7K | ﹤0.01% | 2177 |
|
|
2016
Q3 | $854K | Sell |
56,079
-429,541
| -88% | -$6.54M | ﹤0.01% | 2091 |
|
|
2016
Q2 | $18.9M | Sell |
485,620
-187
| -0% | -$7.26K | 0.01% | 780 |
|
|
2016
Q1 | $13.5M | Buy |
485,807
+46,327
| +11% | +$1.29M | 0.01% | 857 |
|
|
2015
Q4 | $23.6M | Buy |
439,480
+11,729
| +3% | +$631K | 0.01% | 742 |
|
|
2015
Q3 | $17.1M | Buy |
427,751
+288,054
| +206% | +$11.5M | 0.01% | 798 |
|
|
2015
Q2 | $4.46M | Sell |
139,697
-145,250
| -51% | -$4.64M | ﹤0.01% | 1175 |
|
|
2015
Q1 | $6.8M | Sell |
284,947
-55,986
| -16% | -$1.34M | ﹤0.01% | 1044 |
|
|
2014
Q4 | $6.02M | Hold |
340,933
| – | – | ﹤0.01% | 1070 |
|
|
2014
Q3 | $4.67M | Hold |
340,933
| – | – | ﹤0.01% | 1110 |
|
|
2014
Q2 | $5.75M | Hold |
340,933
| – | – | ﹤0.01% | 1070 |
|
|
2014
Q1 | $6.2M | Buy |
+340,933
| New | +$6.2M | ﹤0.01% | 1035 |
|